U.S. flag

An official website of the United States government

NM_022089.4(ATP13A2):c.3057del (p.Tyr1020fs) AND Kufor-Rakeb syndrome

Germline classification:
Pathogenic/Likely pathogenic (3 submissions)
Last evaluated:
Jan 7, 2020
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000541447.9

Allele description [Variation Report for NM_022089.4(ATP13A2):c.3057del (p.Tyr1020fs)]

NM_022089.4(ATP13A2):c.3057del (p.Tyr1020fs)

Gene:
ATP13A2:ATPase cation transporting 13A2 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
1p36.13
Genomic location:
Preferred name:
NM_022089.4(ATP13A2):c.3057del (p.Tyr1020fs)
Other names:
p.Tyr1020Thrfs*3
HGVS:
  • NC_000001.11:g.16987072del
  • NG_009054.1:g.29857del
  • NM_001141973.3:c.3042del
  • NM_001141974.3:c.2925del
  • NM_022089.4:c.3057delMANE SELECT
  • NP_001135445.1:p.Tyr1015fs
  • NP_001135446.1:p.Tyr976fs
  • NP_071372.1:p.Tyr1020fs
  • LRG_834t1:c.3057del
  • LRG_834:g.29857del
  • LRG_834p1:p.Tyr1020fs
  • NC_000001.10:g.17313567del
  • NM_022089.2:c.3057del
  • NM_022089.2:c.3057delC
  • NM_022089.3:c.3057del
  • NM_022089.3:c.3057delC
  • p.Y1020Tfs*3
Protein change:
Y1015fs
Links:
OMIM: 610513.0001; dbSNP: rs765632065
NCBI 1000 Genomes Browser:
rs765632065
Molecular consequence:
  • NM_001141973.3:c.3042del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001141974.3:c.2925del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_022089.4:c.3057del - frameshift variant - [Sequence Ontology: SO:0001589]
Observations:
1

Condition(s)

Name:
Kufor-Rakeb syndrome (KRS)
Synonyms:
Park 9; Pallidopyramidal degeneration with supranuclear upgaze paresis, and dementia; PARKINSON DISEASE 9, AUTOSOMAL RECESSIVE, JUVENILE-ONSET
Identifiers:
MONDO: MONDO:0011706; MedGen: C1847640; Orphanet: 306674; Orphanet: 314632; OMIM: 606693

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000021427OMIM
no assertion criteria provided
Pathogenic
(Aug 26, 2011)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

SCV000915371Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification Criteria 09 May 2019)
Likely pathogenic
(Apr 28, 2017)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link,

SCV001432760Undiagnosed Diseases Network, NIH - Undiagnosed Diseases Network (NIH), UDN
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jan 7, 2020)
maternalclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
Caucasiansmaternalyes11not providednot providednot providedclinical testing

Citations

PubMed

Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein.

Tan J, Zhang T, Jiang L, Chi J, Hu D, Pan Q, Wang D, Zhang Z.

J Biol Chem. 2011 Aug 26;286(34):29654-62. doi: 10.1074/jbc.M111.233874. Epub 2011 Jul 1.

PubMed [citation]
PMID:
21724849
PMCID:
PMC3191006

Mutant Atp13a2 proteins involved in parkinsonism are degraded by ER-associated degradation and sensitize cells to ER-stress induced cell death.

Ugolino J, Fang S, Kubisch C, Monteiro MJ.

Hum Mol Genet. 2011 Sep 15;20(18):3565-77. doi: 10.1093/hmg/ddr274. Epub 2011 Jun 10.

PubMed [citation]
PMID:
21665991
PMCID:
PMC3159557
See all PubMed Citations (6)

Details of each submission

From OMIM, SCV000021427.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In a nonconsanguineous Chilean family in which 3 males and 1 female in a sibship of 11 were affected with the early-onset parkinsonism resembling that of Kufor-Rakeb syndrome (KRS; 606693), Ramirez et al. (2006) found 2 mutations of the ATP13A2 gene in compound heterozygosity. The mutation inherited from the mother was deletion of a cytosine at nucleotide position 3057 in exon 26, leading to a frameshift and stop codon after 2 extraneous amino acids (3057delC, 1019GlyfsTer1021). The second mutation, inherited from the father, was a guanine-to-adenine transition at position +5 of the donor splice site of exon 13 (1306+5G-A; 610513.0002).

By confocal analysis of human, mouse, and rat cells transfected with ATP13A2 cDNA containing the 3057C deletion, Tan et al. (2011) found that the mutant protein was not targeted to lysosomes, but was retained in the endoplasmic reticulum.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Illumina Laboratory Services, Illumina, SCV000915371.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

The ATP13A2 c.3057delC (p.Tyr1020ThrfsTer3) variant is a frameshift variant and is predicted to result in a premature termination of the protein. The variant has been reported in a compound heterozygous state in four siblings of a large non-consanguineous Chilean family with Kufor-Rakeb syndrome (Ramirez et al. 2006). The variant segregates with disease in this family over two generations, with three unaffected siblings and the mother carrying the p.Tyr1020ThrfsTer3 variant in a heterozygous state. Further evaluation of this same family by Bruggemann et al. (2010) showed that the p.Tyr1020ThrfsTer3 variant in single heterozygous state may be a risk allele for later onset Parkinsonism. Control data are unavailable for this variant, which is reported at a frequency of 0.00021 in the European (non-Finnish) population of the Exome Aggregate Consortium. Functional studies demonstrated that the p.Tyr1020ThrfsTer3 variant protein is mislocalized to the endoplasmic reticulum and is targeted for degradation via the proteasome (Ramirez et al. 2006; Ugolino et al. 2011; Podhajska et al. 2012). Based on the available evidence and the potential impact of frameshift variants, the p.Tyr1020ThrfsTer3 variant is classified as likely pathogenic for Kufor-Rakeb syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Undiagnosed Diseases Network, NIH - Undiagnosed Diseases Network (NIH), UDN, SCV001432760.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Caucasians1not providednot providedclinical testing PubMed (1)

Description

The c.3057delC variant has been previously reported as disease-causing in PMIDs 22296644, 21724849, 29966207, 16964263, 21665991.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1maternalyesnot providedbloodnot provided1not provided1not provided

Last Updated: Nov 30, 2024